A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
Histaminergic agents are known to be involved with the sleep/wake cycle. This compound is a
histaminergic agent which therefore may improve alertness and awakeness in patients with
excessive daytime sleepiness (EDS) associated with narcolepsy. Significant improvement in EDS
when treated with this compound compared to placebo in patients with narcolepsy is
hypothesized.